Autolus Therapeutics
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
Revenue | $20,923 | $8,982 | $29 | $0 |
Gross Profit | -3,522 | -8,969 | -13,435 | -223 |
EBITDA | -65,240 | -54,902 | -69,448 | |
EBIT | -67,517 | -56,979 | -71,386 | |
Net Income | -47,917 | -70,161 | -27,606 | -82,094 |
Net Change In Cash | 20,923 | 8,982 | 29 | 0 |
Free Cash Flow | -80,058 | -83,808 | -61,790 | -86,329 |
Cash | 123,825 | 95,799 | 227,380 | 657,067 |
Basic Shares | 266,125 | 266,126 | 266,125 | 266,084 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $10,120 | $1,698 | $6,194 | $2,330 |
Gross Profit | -1,267 | -4,867 | -131,026 | -126,321 |
EBITDA | -182,424 | -156,770 | -135,536 | -132,006 |
EBIT | -190,140 | -163,335 | -142,958 | -140,554 |
Net Income | -220,662 | -208,383 | -148,839 | -142,096 |
Net Change In Cash | 10,120 | 1,698 | 6,194 | 2,330 |
Free Cash Flow | -241,090 | -156,573 | -123,149 | -126,718 |
Cash | 227,380 | 239,566 | 382,436 | 310,338 |
Basic Shares | 255,161 | 173,941 | 94,993 | 72,084 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | $0 |
2025-06-30 | -$0.18 |
2025-03-31 | -$0.26 |
2024-12-31 | -$0.09 |
